We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
APVO icon
526
Aptevo Therapeutics
APVO
$5.12M
$5.12M $4.11 0.48%
HCWB icon
527
HCW Biologics
HCWB
$5.11M
$5.11M $3.20 1.59%
JUNS
528
Jupiter Neurosciences
JUNS
$5.09M
$5.09M $0.0900 7.69%
BGMS
529
Bio Green Med Solution Inc
BGMS
$4.91M
$4.91M $0.8900 2.51%
JAGX icon
530
Jaguar Health
JAGX
$4.91M
$4.91M $1 3.85%
MLEC icon
531
Moolec Science
MLEC
$4.88M
$4.88M $6.73 6.53%
RNAZ icon
532
TransCode Therapeutics
RNAZ
$4.83M
$4.83M $4.56 13.1%
SILO icon
533
Silo Pharma
SILO
$4.73M
$4.73M $4.19 1.41%
DRMA icon
534
Dermata Therapeutics
DRMA
$4.71M
$4.71M $1.17 0.85%
CDIO icon
535
Cardio Diagnostics
CDIO
$4.62M
$4.62M $1.56 0.64%
TCRT icon
536
Alaunos Therapeutics
TCRT
$4.59M
$4.59M $1.88 0%
MBIO icon
537
Mustang Bio
MBIO
$4.32M
$4.32M $0.5702 3.97%
CELZ icon
538
Creative Medical Technology
CELZ
$4.31M
$4.31M $0.6640 13.1%
FBLG icon
539
FibroBiologics
FBLG
$4.26M
$4.26M $0.7000 2.67%
ELAB icon
540
Elevai Labs
ELAB
$4.19M
$4.19M $0.9229 2.78%
SPRC icon
541
SciSparc
SPRC
$4.08M
$4.08M $7.12 18.2%
ENSC icon
542
Ensysce Biosciences
ENSC
$3.89M
$3.89M $0.2530 1.56%
ERNA icon
543
Eterna Therapeutics
ERNA
$3.83M
$3.83M $3.28 5.48%
REVB icon
544
Revelation Biosciences
REVB
$3.71M
$3.71M $0.9500 4.56%
XRTX
545
XORTX Therapeutics
XRTX
$3.67M
$3.67M $2.12 4.95%
GOVX icon
546
GeoVax Labs
GOVX
$3.55M
$3.55M $0.6812 3.05%
LABT
547
Lakewood-Amedex Biotherapeutics
LABT
$3.54M
$3.54M $2.02 4.66%
SXTP icon
548
60 Degrees Pharmaceuticals
SXTP
$3.11M
$3.11M $1.17 6.4%
ONCO icon
549
Onconetix
ONCO
$3.05M
$3.05M $0.8267 5.12%
GNPX icon
550
Genprex
GNPX
$3.02M
$3.02M $5.99 1.16%

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.2T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $121B, Regeneron Pharmaceuticals (REGN) at $78.5B and argenx (ARGX) at $53.4B.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.